Loading clinical trials...
Loading clinical trials...
Background Portal hypertension (PH) is a spectrum of complications of end-stage liver disease (ESLD) and cirrhosis, with severe manifestations including ascites and gastroesophageal varices. It is the...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Leiden University Medical Center
NCT02417740 · Cystic Fibrosis, Immunologic Deficiency Syndrome, and more
NCT07439939 · Liver Cirrhosis, Portal Hypertension
NCT06205992 · Cirrhosis, Liver Portal Hypertension
NCT06669806 · Portal Hypertension Related to Cirrhosis, Ascites Hepatic, and more
NCT07163689 · TIPS, Portal Hypertension, and more
Leiden University Medical Center
Leiden, South Holland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions